Average Co-Inventor Count = 8.55
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (15 from 2,405 patents)
2. Merck Canada Inc. (4 from 40 patents)
15 patents:
1. 11702430 - Aza-benzothiophene compounds as STING agonists
2. 11008338 - C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
3. 10689401 - C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
4. 10414774 - Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
5. 10414775 - Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
6. 9732088 - C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their use
7. 9376418 - Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
8. 9242984 - Pyrazolyl derivatives as Syk inhibitors
9. 9145391 - Bipyridylaminopyridines as Syk inhibitors
10. 8946237 - Pyrazolo[1,5-A]pyrimidines as mark inhibitors
11. 8796310 - Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors
12. 8592425 - Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors
13. 8551984 - Aminopyrimidines as SYK inhibitors
14. 8431569 - Inhibitors of janus kinases
15. 8367706 - Inhibitors of janus kinases